1. Home
  2. RLAY vs NVTS Comparison

RLAY vs NVTS Comparison

Compare RLAY & NVTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$8.29

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Navitas Semiconductor Corporation

NVTS

Navitas Semiconductor Corporation

HOLD

Current Price

$7.23

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
NVTS
Founded
2015
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.8B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
RLAY
NVTS
Price
$8.29
$7.23
Analyst Decision
Strong Buy
Buy
Analyst Count
7
6
Target Price
$16.00
$5.92
AVG Volume (30 Days)
2.2M
14.1M
Earning Date
11-06-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,355,000.00
$56,598,000.00
Revenue This Year
$20.47
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.78
$1.52
52 Week High
$9.04
$17.79

Technical Indicators

Market Signals
Indicator
RLAY
NVTS
Relative Strength Index (RSI) 57.67 37.12
Support Level $8.13 $7.36
Resistance Level $8.76 $8.13
Average True Range (ATR) 0.48 0.53
MACD -0.01 -0.05
Stochastic Oscillator 54.63 5.15

Price Performance

Historical Comparison
RLAY
NVTS

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About NVTS Navitas Semiconductor Corporation

Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components for use in mobile device and other markets. Geographically, the company operates in China, Europe, United States, Rest of Asia and Others. The majority of revenue is generated from China.

Share on Social Networks: